Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pease

Showing results (201-210 of 213) with videos related to

Pageof 22
Sort By:
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 26, 2023
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1Luciana L Almada, Kim Barroso, Sandhya Sen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2020
Conditional Silencing of H-2D<sup>b</sup> Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus InfectionZachariah P Tritz, Robin C Orozco, Courtney S Malo, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigensJames William Jenkins, Alvaro Peña, Sarah A Castro, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2025
Nuclear Galectin-1 promotes <i>KRAS</i>-dependent activation of pancreatic cancer stellate cellsJudith Vinaixa, Neus Martínez-Bosch, Joan Gibert, et al.
Brain : a Journal of Neurology|November 30, 2020
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediatorsKatayoun Ayasoufi, Christian K Pfaller, Laura Evgin, et al.
The Journal of Biological Chemistry|May 28, 2026
KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53Ezequiel J Tolosa, Glancis L Raja Arul, Ashley N Sigafoos, et al.
Blood|November 23, 2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenograftsRosalie M Sterner, Reona Sakemura, Michelle J Cox, et al.
Nature Communications|April 15, 2020
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomasJay Daniels, Peter G Doukas, Maria E Martinez Escala, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Blood|June 11, 2021
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneityJoonhee Park, Jay Daniels, Tim Wartewig, et al.
Pageof 22

Showing results (201-210 of 213) with videos related to

Sort By:
Pageof 22
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|February 26, 2023
GLI1, a novel target of the ER stress regulator p97/VCP, promotes ATF6f-mediated activation of XBP1Luciana L Almada, Kim Barroso, Sandhya Sen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 2, 2020
Conditional Silencing of H-2D<sup>b</sup> Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses during Theiler's Virus InfectionZachariah P Tritz, Robin C Orozco, Courtney S Malo, et al.
Journal for Immunotherapy of Cancer|April 5, 2025
MHC class II-mediated spontaneous rejection of breast carcinomas expressing model neoantigensJames William Jenkins, Alvaro Peña, Sarah A Castro, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2025
Nuclear Galectin-1 promotes <i>KRAS</i>-dependent activation of pancreatic cancer stellate cellsJudith Vinaixa, Neus Martínez-Bosch, Joan Gibert, et al.
Brain : a Journal of Neurology|November 30, 2020
Brain cancer induces systemic immunosuppression through release of non-steroid soluble mediatorsKatayoun Ayasoufi, Christian K Pfaller, Laura Evgin, et al.
The Journal of Biological Chemistry|May 28, 2026
KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53Ezequiel J Tolosa, Glancis L Raja Arul, Ashley N Sigafoos, et al.
Blood|November 23, 2018
GM-CSF inhibition reduces cytokine release syndrome and neuroinflammation but enhances CAR-T cell function in xenograftsRosalie M Sterner, Reona Sakemura, Michelle J Cox, et al.
Nature Communications|April 15, 2020
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomasJay Daniels, Peter G Doukas, Maria E Martinez Escala, et al.
JCI Insight|June 10, 2025
Emerin is an effector of oncogenic KRAS-driven nuclear dynamics in pancreatic cancerLuis F Flores, David L Marks, Renzo E Vera, et al.
Blood|June 11, 2021
Integrated genomic analyses of cutaneous T-cell lymphomas reveal the molecular bases for disease heterogeneityJoonhee Park, Jay Daniels, Tim Wartewig, et al.
Pageof 22